• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肛周瘘管和脓肿的治疗:克罗恩病型与非克罗恩病型。

Treatment of Perianal Fistula and Abscess: Crohn's and Non-Crohn's.

作者信息

Mardini Houssam E, Schwartz David A

机构信息

David A. Schwartz, MD Director, Inflammatory Bowel Disease Center, Vanderbilt University Medical Center, 1501 TVC, Nashville, TN 37232, USA.

出版信息

Curr Treat Options Gastroenterol. 2007 Jun;10(3):211-20. doi: 10.1007/s11938-007-0014-2.

DOI:10.1007/s11938-007-0014-2
PMID:17547859
Abstract

The management of perianal abscesses and fistulas is relatively straightforward in most cases and based on a sound knowledge of the anatomy of the anorectum and adherence to established medical and surgical principles. Asymptomatic fistulas should not be treated, whereas abscesses require surgical drainage under general anesthesia. Fistula treatment includes drainage of any associated sepsis and eradication of the fistula track to prevent recurrence while preserving sphincter integrity. A small percentage of anal abscesses and fistulas are complex and very challenging to manage, particularly in conditions such as rectovaginal fistulas and abscesses and/or fistulas complicating Crohn's disease. Treatment strategies in these situations rely on an accurate clinical assessment of the degree of rectal inflammation and perianal pathology. Treatment should combine aggressive medical therapy (antibiotics, immunomodulators, and anti-tumor necrosis factor antibody treatment) and minimal surgical interventions. Patients with proctitis have a significantly lower healing rate and a significantly higher complication rate with aggressive surgical interventions.

摘要

在大多数情况下,肛周脓肿和肛瘘的处理相对简单,基于对肛管直肠解剖结构的扎实了解以及遵循既定的医学和外科原则。无症状的肛瘘不应治疗,而脓肿需要在全身麻醉下进行手术引流。肛瘘的治疗包括引流任何相关的脓毒症以及根除瘘管以防止复发,同时保持括约肌的完整性。一小部分肛门脓肿和肛瘘情况复杂,处理极具挑战性,尤其是在直肠阴道瘘以及克罗恩病并发的脓肿和/或肛瘘等情况下。这些情况下的治疗策略依赖于对直肠炎症程度和肛周病变的准确临床评估。治疗应结合积极的药物治疗(抗生素、免疫调节剂和抗肿瘤坏死因子抗体治疗)以及最小限度的手术干预。对于直肠炎患者,积极的手术干预会使其愈合率显著降低,并发症发生率显著升高。

相似文献

1
Treatment of Perianal Fistula and Abscess: Crohn's and Non-Crohn's.肛周瘘管和脓肿的治疗:克罗恩病型与非克罗恩病型。
Curr Treat Options Gastroenterol. 2007 Jun;10(3):211-20. doi: 10.1007/s11938-007-0014-2.
2
Perianal Crohn's disease. Results of local surgical treatment.肛周克罗恩病。局部手术治疗结果。
Dis Colon Rectum. 1996 May;39(5):529-35. doi: 10.1007/BF02058706.
3
Perianal abscess in Crohn's disease.克罗恩病中的肛周脓肿
Dis Colon Rectum. 1997 Apr;40(4):443-50. doi: 10.1007/BF02258390.
4
Multidisciplinary and evidence-based management of fistulizing perianal Crohn's disease.肛周克罗恩病肛瘘的多学科循证管理
World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):239-51. doi: 10.4291/wjgp.v5.i3.239.
5
Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.抗肿瘤坏死因子-α(英夫利昔单抗)在克罗恩病中用于活动性直肠炎的多步骤诱导治疗,随后对复杂性肛瘘进行确定性手术:一份初步报告。
Dis Colon Rectum. 2005 Apr;48(4):758-67. doi: 10.1007/s10350-004-0828-0.
6
Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.使用内镜超声引导对克罗恩病肛周瘘患者进行药物与手术联合治疗。
Inflamm Bowel Dis. 2005 Aug;11(8):727-32. doi: 10.1097/01.mib.0000172811.57242.18.
7
Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.克罗恩病的肛门直肠病变:法国临床实践推荐。
Tech Coloproctol. 2017 Sep;21(9):683-691. doi: 10.1007/s10151-017-1684-y. Epub 2017 Sep 19.
8
Ligation of the Intersphincteric Fistula Tract and Endorectal Advancement Flap for High Perianal Fistulas in Crohn's Disease: A Retrospective Cohort Study.括约肌间瘘管结扎术和经直肠内推移皮瓣术治疗克罗恩病高位肛周瘘:一项回顾性队列研究。
J Crohns Colitis. 2020 Jul 9;14(6):757-763. doi: 10.1093/ecco-jcc/jjz181.
9
Perianal inflammatory conditions in inflammatory bowel disease.炎症性肠病中的肛周炎症性疾病
Curr Opin Gen Surg. 1993:141-6.
10
[Perianal fistulas in Crohn's disease: treatment results at an interdisciplinary unit].[克罗恩病中的肛周瘘管:一个跨学科单位的治疗结果]
Chirurg. 2009 Jun;80(6):549-58. doi: 10.1007/s00104-009-1706-z.

本文引用的文献

1
Adalimumab maintenance therapy for Crohn's disease with intolerance or lost response to infliximab: an open-label study.阿达木单抗用于对英夫利昔单抗不耐受或反应丧失的克罗恩病维持治疗:一项开放标签研究。
Aliment Pharmacol Ther. 2007 Mar 15;25(6):675-80. doi: 10.1111/j.1365-2036.2007.03254.x.
2
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.阿达木单抗用于维持克罗恩病患者的临床反应和缓解:CHARM试验
Gastroenterology. 2007 Jan;132(1):52-65. doi: 10.1053/j.gastro.2006.11.041. Epub 2006 Nov 29.
3
Efficacy of anal fistula plug in closure of cryptoglandular fistulas: long-term follow-up.
肛瘘塞治疗腺源性肛瘘闭合的疗效:长期随访
Dis Colon Rectum. 2006 Dec;49(12):1817-21. doi: 10.1007/s10350-006-0755-3.
4
Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.肛瘘性肛门克罗恩病:手术联合英夫利昔单抗治疗的结果
Dis Colon Rectum. 2006 Dec;49(12):1837-41. doi: 10.1007/s10350-006-0656-5.
5
Efficacy of anal fistula plug in closure of Crohn's anorectal fistulas.肛瘘塞治疗克罗恩病肛门直肠瘘的疗效
Dis Colon Rectum. 2006 Oct;49(10):1569-73. doi: 10.1007/s10350-006-0695-y.
6
Risks and benefits of infliximab for the treatment of Crohn's disease.英夫利昔单抗治疗克罗恩病的风险与益处
Clin Gastroenterol Hepatol. 2006 Aug;4(8):1017-24; quiz 976. doi: 10.1016/j.cgh.2006.05.020. Epub 2006 Jul 14.
7
Gracilis muscle transposition for fistulas between the rectum and urethra or vagina.股薄肌转位术治疗直肠与尿道或阴道瘘
Dis Colon Rectum. 2006 Sep;49(9):1316-21. doi: 10.1007/s10350-006-0585-3.
8
Management of perianal Crohn's disease.肛周克罗恩病的管理
Clin Gastroenterol Hepatol. 2006 Apr;4(4):426-30. doi: 10.1016/j.cgh.2006.02.001.
9
American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.美国胃肠病学会关于皮质类固醇、免疫调节剂和英夫利昔单抗在炎症性肠病中的应用的技术综述。
Gastroenterology. 2006 Mar;130(3):940-87. doi: 10.1053/j.gastro.2006.01.048.
10
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.人抗肿瘤坏死因子单克隆抗体(阿达木单抗)治疗克罗恩病:CLASSIC - I试验
Gastroenterology. 2006 Feb;130(2):323-33; quiz 591. doi: 10.1053/j.gastro.2005.11.030.